ALTU Altus Pharmaceuticals Inc. featured news, full reports, and detailed charts
Altus Pharmaceuticals Inc. (ALTU) Wrap Up:
We were incorporated in Massachusetts in October 1992 as a wholly-owned subsidiary of Vertex Pharmaceuticals Incorporated, or Vertex, from whom we exclusively license specified patents underlying some of our product candidates. In February 1999, we were reorganized as an independent company, and in August 2001 we reincorporated in Delaware. Prior to May 2004, we were named Altus Biologics Inc. We have one subsidiary, Altus Pharmaceuticals Securities Corp., a Massachusetts corporation. Unless the context requires otherwise, references to “Altus,” “we,” “our”, “us” and “the Registrant” in this report refer to Altus Pharmaceuticals Inc. and our subsidiary. Our principal executive offices are located at 640 Memorial Drive, Cambridge, MA 02139, and our telephone number is (617) 299-2900. Our website address is www.altus.com. The information contained on, or that can be accessed through, our website is not incorporated by reference into this report. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f11%2f0000950135-08-001703.html#FIS_BUSINESS"Altus Pharmaceuticals Inc. (ALTU*(H):NASDAQ)
Snapshot of Altus Pharmaceuticals Inc. (ALTU)
|
OPEN
$0.05
|
PREVIOUS CLOSE
$0.05
|
|
|
DAY HIGH
$0.14
|
DAY LOW
$0.05
|
|
|
52 WEEK HIGH
12/18/08 - $0.75
|
52 WEEK LOW
11/12/09 - $0.01
|
|
|
MARKET CAP
2.8M
|
AVERAGE VOLUME 3 mo
3.5M
|
|
|
DILUTED EPS TTM
$-2.33
|
SHARES OUTSTANDING
31.1M
|
|
|
ALTU Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
related news
Five for the Money's latest look at one of the riskiest sectors of the market identifies a handful of promising drug development companies
ALTU Top Compensated Officers
Executives, Board Directors
Key developments for Altus Pharmaceuticals Inc. (ALTU)
On October 29, 2009, the board of directors of Altus Pharmaceuticals Inc. determined to discontinue the employment of Georges Gemayel, Ph.D. and Thomas J. Phair, Jr., with Dr. Gemayal to continue as a director and Gemayel and Phair both to continue as statutory officers without compensation pending the wind down of operations.
Altus Pharmaceuticals Inc. expected to Report Q3 2009 Results on November 23, 2009. This event was calculated by Capital IQ (Created on November 2, 2009).
Altus Pharmaceuticals Inc. announced that on September 15, 2009, the Company received a letter from the NASDAQ Listing Qualifications Department notifying the Company that, for the last 30 consecutive business days, the bid price of the Companys common stock has closed below the minimum $1.00 per share required for continued listing on the NASDAQ Capital Market under NASDAQ Listing Rule 5550(a)(2). In accordance with NASDAQ Listing Rule 5810(c)(3)(A), NASDAQ will provide the Company with 180 calendar days, or until March 15, 2010, to regain compliance. If at any time before March 15, 2010 the bid price of the Companys common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, NASDAQ will provide written notification that the Company has achieved compliance with NASDAQ Listing Rule 5550(a)(2). If the Company does not meet this requirement, the Companys common stock may be delisted. In addition, in light of the Companys disclosure that it has commenced a process to wind down the business of the Company, the Company received a letter from NASDAQ on September 16, 2009 requesting the Company to supply certain information in order to enable NASDAQ to determine whether the Company may be deemed a public shell. If NASDAQ determines that the Company is a public shell, NASDAQ may, under NASDAQ Listing Rule 5100, determine to delist the Companys common stock, even if the Company regains compliance with the minimum bid price rule.
ALTU Competitors
| Company | Last | Change | |
| No competitor information is available for ALTU. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | ALTU | Industry Range |
| No financial data is available for ALTU. | ||
ALTU transactions
| Type Date |
Target |
|
Bankruptcy
November 11, 2009 |
-- |